Related Experiment Videos
Genetic therapy of human neoplastic disease
A B Deisseroth1, E G Hanania, S Fu
1Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Abstract:
Molecular biology has provided clinical investigators and basic scientists with the tools to identify those changes present within neoplastic hematopoietic and epithelial cells that lead to the evolution of unregulated patterns of cell growth. This information has made possible the development of therapy that involves genetic modification of either the normal hematopoietic cells (for chemoprotection), or the tumor cells themselves to suppress the growth of these cells. This article will summarize the clinical and laboratory data that is evolving in this area.
Insights
Molecular biology advances enable targeted cancer therapies by genetically modifying hematopoietic or tumor cells. This approach aims to suppress tumor growth and enhance chemoprotection, offering new treatment strategies.
Area of Science:
- Molecular biology
- Cancer research
- Genetics
Background:
- Neoplastic cell growth involves unregulated proliferation in hematopoietic and epithelial cells.
- Molecular biology tools allow identification of genetic changes driving cancer.
- Understanding these changes is crucial for developing targeted therapies.
Purpose of the Study:
- To summarize evolving clinical and laboratory data in molecularly targeted cancer therapy.
- To highlight the application of genetic modification in cancer treatment.
Main Methods:
- Review of clinical and laboratory data.
- Analysis of genetic modification techniques in cancer therapy.
Main Results:
- Identification of specific genetic alterations in neoplastic cells.
- Development of therapies involving genetic modification of normal or tumor cells.
Conclusions:
- Genetic modification holds promise for cancer chemoprotection and tumor growth suppression.
- Ongoing research continues to refine these molecularly targeted therapeutic strategies.